EPHB2 and colorectal carcinoma: In a study of mutations in the A9 region of EPHB2 and microsatellite instability in 481 CRC patients, Rafael and colleagues found that the risk of recurrence of tumors with high microsatellite instability carrying the EPHB2 mutation was 3.6 times higher in carriers without a mutation (134).